Concert Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-7,286
Closed -$475K 348
2017
Q1
$475K Sell
7,286
-154
-2% -$10.3K 0.11% 259
2016
Q4
$485K Sell
7,440
-2,546
-25% -$165K 0.11% 257
2016
Q3
$708K Sell
9,986
-266
-3% -$19.4K 0.09% 294
2016
Q2
$759K Buy
10,252
+522
+5% +$36.1K 0.1% 255
2016
Q1
$629K Sell
9,730
-483
-5% -$32.9K 0.08% 292
2015
Q4
$789K Sell
10,213
-1,256
-11% -$99.8K 0.11% 244
2015
Q3
$939K Buy
11,469
+419
+4% +$37.3K 0.13% 209
2015
Q2
$975K Buy
11,050
+753
+7% +$69.1K 0.13% 209
2015
Q1
$388K Sell
10,297
-201
-2% -$17.8K 0.11% 250
2014
Q4
$876K Buy
10,498
+942
+10% +$78.1K 0.13% 204
2014
Q3
$801K Sell
9,556
-865
-8% -$70K 0.11% 176
2014
Q2
$809K Buy
10,421
+1,106
+12% +$87K 0.1% 179
2014
Q1
$676K Buy
9,315
+532
+6% +$38.8K 0.08% 209
2013
Q4
$630K Buy
8,783
+222
+3% +$15.4K 0.08% 212
2013
Q3
$590K Hold
8,561
0.08% 221
2013
Q2
$541K Buy
+8,561
New +$557K 0.08% 209

Other funds holding NVS

Concert Wealth Management's NVS Position: Q2 2017 in Review

Concert Wealth Management sold out of Novartis (NVS) in Q2 2017, closing a stake of 7,286 shares — an estimated $475K sold.

Concert Wealth Management first reported a position in NVS in Q2 2013 and held it in 16 quarters. The position peaked at $975K in Q2 2015. 920 funds tracked by Wall St. Rank hold NVS as of Q2 2017.

  • Concert Wealth Management reported no remaining Novartis position as of Q2 2017 after selling out during the quarter.
  • Concert Wealth Management sold 7,286 Novartis shares in Q2 2017, an estimated $475K.
  • Concert Wealth Management first reported a position in Novartis in Q2 2013 and held it in 16 quarters.
  • Concert Wealth Management's Novartis position peaked at $975K in Q2 2015.
  • 920 funds tracked by Wall St. Rank held Novartis as of Q2 2017.

Based on Concert Wealth Management's 13F filing for Q2 2017, filed 10 Aug 2017.